s6y
Company name or ticker
Search
Helus Pharma Inc.
6-K
Current report (foreign issuer)
Filed
Thursday, March 12, 2026
Period
Mar 12, 2026
Accession number
0001833141-26-000020
Documents
Current report (foreign issuer)
6-K
99.1
Press release or other material
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header